Home - Neurological Disorders - MengPing® Fazamorexant | Insomnia Disorder | DengYueRX
Description
Indication & Scope
MengPing (Fazamorexant) is an orexin receptor antagonist indicated for the treatment of adult insomnia characterized by difficulty initiating sleep and/or maintaining sleep.
- Mechanism: Fazamorexant blocks orexin signaling by antagonizing orexin receptors, regulating the sleep–wake cycle and promoting sleep initiation and maintenance.
- Drug class: Dual orexin receptor antagonist (DORA).
- Clinical use: Treatment of insomnia disorder in adults with sleep initiation and/or sleep maintenance difficulties.
| Generic Name | Fazamorexant |
| Brand Name | MengPing® |
| Ingredient | Each tablet contains fazamorexant 20 mg. |
| Dosage Form | Tablet |
| Package | 20 mg × 10 tablets/box |
| Conditions Treated | Treatment of adult patients with insomnia characterized by difficulty in falling asleep and/or difficulty maintaining sleep. |
| Taboos | Hypersensitivity to fazamorexant or any component of the product. |
| Place of origin | China |
| Prescription type | Prescription Drug (Rx) |
| Storage Conditions | Refer to the approved package labeling. |
| Manufacturer | Jiangsu Coast Pharmaceutical Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H20260025 |
| Date of Revision | 2026 |
| Shelf Life | Refer to the approved package labeling |
How to use ?
Recommended Dose: The recommended dose of Fazamorexant is 20 mg taken orally once daily before bedtime.
Time: Administer once daily at bedtime according to the approved treatment regimen.
Instructions for use: Take orally before bedtime. Ensure sufficient time for sleep after administration. Do not exceed the recommended dose. Use according to the approved prescribing information.
Interaction: Fazamorexant may interact with drugs that affect CYP enzyme activity, especially strong or moderate CYP3A inhibitors or inducers. Refer to the approved package labeling for detailed drug interaction information.
Side effects: The most common adverse reactions include somnolence, dizziness, fatigue, abnormal dreams, and headache. Refer to the approved package labeling for complete safety information.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What is MengPing used for?
MengPing is used for the treatment of adult patients with insomnia characterized by difficulty falling asleep and/or difficulty maintaining sleep.
How should MengPing be taken?
MengPing should be taken orally according to the approved prescribing information, usually before bedtime.
Can this be taken every night?
Use should follow the physician’s prescription and the approved dosing instructions.
How long does it take to work?
It is designed to help improve sleep initiation and sleep maintenance. Individual responses may vary, and treatment effects should be evaluated according to clinical guidance.
MengPing® Fazamorexant | Insomnia Disorder | DengYueRX
INN: Fazamorexant
Indications: Treatment of adult patients with insomnia
Dosage Form: Tablet
Strength: 20 mg/tablet